Gut and cancer: what the gut microbiota protects against, what harms, and why it matters in cancer treatment
Fibre and its bacteria protect against colorectal cancer, while some bacteria damage the genome. Why colorectal cancer is rising in people under 50, which germs travel along in tumours, what Helicobacter has to do with stomach cancer, and why the gut microbiota helps decide whether immunotherapy works.
How solid is the research? Trust score 3 of 5:Promising
Well established are the benefit of screening colonoscopies, the link of fibre and processed meat with colorectal cancer, and that of Helicobacter with stomach cancer. That certain bacteria damage the genome of gut cells is clearly shown in the lab, but their share of human cancer cases is still unclear. The role of the gut microbiota in immunotherapy rests on animal studies, observations and small trials.
Cause or consequence? Root cause 2 of 5:Rather a consequence
Colorectal cancer is usually the end of a long chain of predisposition, diet, inflammation and gut microbiota, rarely its beginning. But it can have consequences of its own, such as iron deficiency from unnoticed bleeding.
Healthy state
The lining of the gut renews itself completely every few days. For this, stem cells deep in the pits of the gut wall divide constantly. Each division can introduce an error in the genome, and usually the body repairs or removes the affected cell. If certain errors build up over years, a polyp can form and, very slowly, colorectal cancer can develop from it. Because this takes so long, colorectal cancer can often be prevented by screening colonoscopies: polyps are simply removed during the procedure.
What reaches the colon shapes the environment of these cells. Bacteria ferment fibre into Short-chain fatty acids Acids such as acetate, propionate and butyrate that gut bacteria make from fibre. They nourish the gut wall and act throughout the body. More in the chapter “Butyrate and other short-chain fatty acids”, above all Butyrate A short-chain fatty acid and the main energy source for the cells of the colon wall. It strengthens the barrier and dampens inflammation. More in the chapter “Butyrate and other short-chain fatty acids”. Healthy gut cells use butyrate as their main fuel; it seals the wall and calms the immune system. A large analysis of 185 observational studies found that people who ate the most fibre had a 15 to 30 percent lower risk of colorectal cancer and other chronic diseases. The benefit was clearest from 25 to 29 grams a day.
An exchange experiment showed how quickly diet changes the gut environment. Colorectal cancer is more than ten times as common in African Americans as in people in rural South Africa. For two weeks, African Americans ate a high-fibre, low-fat African diet and South Africans a high-fat, low-fibre Western diet. The values reversed almost like a mirror image: in the African Americans, butyrate production rose and fewer secondary Bile acids Substances made by the liver that make fat digestible. About 95 percent are reabsorbed in the last part of the small intestine; gut bacteria transform the rest. More in the chapter “Bile acids: when bile causes diarrhoea”, which irritate the lining, were formed. Markers of cell growth in the lining also fell.
The Microbiome, gut microbiota The community of all microbes in the gut, mainly bacteria, plus viruses, fungi and archaea. Most live in the colon. More in the chapter “Building microbial diversity” also trains the immune system, which can recognise and fight cancer cells too. This shows in immunotherapy with so-called checkpoint inhibitors, which release the brake on immune cells. Whether they work was linked to the gut microbiota in several studies. Among 128 people with melanoma, those who ate a lot of fibre lived longer without their disease progressing, most clearly when they did not take Probiotics Live microorganisms that are meant to provide a benefit in sufficient amounts. The effect depends on the individual strain. More in the chapter “Using fermented foods well”.
Disrupted state: causes and effects
Colorectal cancer is one of the most common cancers. Strikingly, it is increasing in people under 50: in many countries the number has doubled over the last two decades. Why is not clear. Diet, overweight, antibiotics and the gut microbiota in childhood are being discussed.
One hot lead points to bacteria. Some strains of Escherichia coli carry a gene cluster called pks and use it to make colibactin, a substance that damages DNA. When researchers exposed lab-grown mini-guts to such bacteria for five months, they left a typical pattern of DNA errors. Exactly this pattern was found in some of almost 6,000 human cancer genomes, especially in colorectal cancer. A study of 981 colorectal cancer genomes from 11 countries found the colibactin pattern 3.3 times more often in people who fell ill before 40 than in those over 70. It had arisen early in cancer development. The researchers therefore suspect that contact with these bacteria in childhood contributes to the rise in younger people. This is not proven.
A second suspect is Fusobacterium nucleatum, a bacterium from the mouth that is particularly common in colorectal tumours. It even travels along into secondary tumours in the liver. The same strains were found in the tumour as in the mouth of the same person. In mice with human colorectal cancer, an antibiotic reduced the fusobacteria and slowed tumour growth. Whether fusobacteria cause cancer or just feel at home in the tumour is unclear. According to a Meta-analysis An analysis that combines the results of several studies. It is only as good as the studies it includes. , a saliva test is not suitable for detecting colorectal cancer.
A third bacterium matters in practice: Streptococcus gallolyticus. When it gets into the blood, for example in an infection of the heart valves, around 60 percent of those affected also had a polyp or colorectal cancer in studies. Such a finding is therefore a reason for a colonoscopy.
Meat and fat act through several routes. The WHO’s cancer research agency classifies processed meat such as sausage and ham as carcinogenic and red meat as probably carcinogenic. Each 50 grams of processed meat a day raises the risk of colorectal cancer by about 18 percent. High-fat diets also stimulate bile release. Gut bacteria turn the bile acids into secondary bile acids such as deoxycholic acid, which irritate the lining and stimulate cell growth in experiments.
Long-lasting inflammation also raises the risk. In ulcerative colitis, the risk of colorectal cancer is about two thirds higher than in the rest of the population. In the stomach, Helicobacter pylori is the main trigger of stomach cancer. In six Randomised trial A study in which chance decides who gets the treatment and who does not, for comparison. This makes results particularly reliable. , mostly from Asia, treatment against Helicobacter lowered the stomach cancer risk of healthy infected people by about one third.
In cancer treatment, a disturbed gut microbiota can weaken the effect. People who received antibiotics around the start of immunotherapy responded less well in one study. When stool from patients who responded to therapy was transferred into germ-free mice, it also worked better there; with stool from non-responders it did not. In a first study in humans, 6 of 15 people with melanoma whose immunotherapy had failed responded again after a stool transfer from patients with a good response.
Conversely, cancer treatment affects the gut. Chemotherapy and radiation to the pelvis cause diarrhoea in 50 to 80 percent of those treated, because they also hit the rapidly dividing cells of the gut lining. This can lead to loss of fluid and nutrients and to breaks in treatment.
Where it comes from and where it leads
The same symptoms can have different roots. This map shows what may be involved in this problem and what may follow from it.
Possible causes. Crohn’s & colitis, Gut immunity, Antibiotics, Low variety, First microbiome. Possible consequences. Nutrient deficiency, Brain fog & fatigue
- Possible causes
- This problem
- Possible consequences
The preview fits the screen width. In the large map you see everything at once.
Move the mouse over a box: its connections are highlighted and everything else steps back.
Tap a box to highlight its connections. Tap it again to open the chapter.
Connections, not certainty: a link means “can”, not “must”. What applies to you is best clarified in a talk with your doctor.
What often helps
Lifestyle
Diet, exercise, sleep, social contact and dealing with stress.
- Fibre as daily protection 25 to 30 grams of fibre a day, from whole grains, legumes, vegetables, fruit and nuts, was linked to the lowest colorectal cancer risk in studies. It feeds the butyrate producers and lowers the amount of irritating bile acids in the colon. With a sensitive gut, increase slowly. Well supported How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [1][2]
- Sausage and ham rarely Processed meat demonstrably raises the risk of colorectal cancer, red meat probably does. It doesn’t have to go completely, but rather as an exception than daily. Legumes, fish or poultry are good alternatives. Well supported How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [3]
- During immunotherapy: high-fibre if possible In an observational study, people on immunotherapy with a high-fibre diet lived longer without their cancer progressing. This is not yet proven, but a high-fibre diet is healthy anyway. If the therapy causes symptoms, agree your diet with your care team. Plausible How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [4]
Natural supplements
Supplements do not replace a medical check-up. Discuss dosage and interactions with your doctor or pharmacist.
- Probiotics during immunotherapy only after discussion In the same study, over-the-counter probiotics tended to go along with a poorer response, and in mice they weakened the effect. That is not proof, but a reason not to take probiotics on your own during immunotherapy. Plausible How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [4]
- Probiotics against diarrhoea during chemo and radiation: uncertain A Cochrane review of 12 studies found signs that probiotics might reduce diarrhoea during radiation and chemotherapy, but the evidence was weak. With a weakened immune system, live germs can themselves cause infections. So only after consulting your care team. Plausible How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [5]
Medical treatments
Information, not a treatment recommendation. Decide together with a doctor. Approval and availability differ from country to country.
- Use colorectal cancer screening A screening colonoscopy finds polyps before they become cancer and removes them right away. In a large European study, people invited to colonoscopy had 18 percent less colorectal cancer after ten years, although only 42 percent went. Stool tests for hidden blood are an alternative. The age at which screening is offered varies by country; ask in your country. Rarely, colonoscopy causes bleeding or an injury to the bowel wall, mainly when polyps are removed. Established How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [6]
- Don’t wait with warning signs Blood in the stool, a new, persistent change in bowel habits, unexplained iron deficiency or weight loss should be checked by a doctor, also in people under 50, in whom colorectal cancer is increasing. Well supported How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [7]
- Test and treat Helicobacter Anyone with stomach complaints or with stomach cancer in the family should be tested for Helicobacter pylori. Treatment lowers the risk of stomach cancer. Afterwards, have the success confirmed with a test. Well supported How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [8][9]
- Antibiotics around immunotherapy only if needed Antibiotics can change the gut microbiota in a way that makes immunotherapy work less well. In a real infection they are still necessary. Tell all treating doctors that you are receiving immunotherapy. Plausible How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [10]
- Streptococcus gallolyticus in the blood: colonoscopy If this bacterium is found in the blood, a large share of those affected have a polyp or colorectal cancer. A colonoscopy is then part of the work-up, even if the gut causes no symptoms. Well supported How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [11]
- With Lynch syndrome: discuss aspirin People with Lynch syndrome, an inherited predisposition to colorectal cancer, received daily aspirin or placebo in a randomised trial with 861 participants. With aspirin, 9 instead of 13 percent developed colorectal cancer over ten years. Whether and at what dose should be decided by a doctor because of the bleeding risk. Well supported How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [12]
- Faecal transplant with immunotherapy: only in studies The first results in melanoma are promising but small. A stool transfer is not without risk when defences are weakened and belongs in clinical trials. Experimental How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [13]
In the mood for something completely different? Another one, at random
How we rate the evidence
- Trust score 5 of 5:Established
- Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies.
- Trust score 4 of 5:Well supported
- Several randomised studies in humans with largely consistent results.
- Trust score 3 of 5:Promising
- Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies.
- Trust score 2 of 5:Plausible
- Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms.
- Trust score 1 of 5:Experimental
- Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open.
Sources
- Reynolds et al. 2019: Carbohydrate quality and health, meta-analyses (Lancet)
- O’Keefe et al. 2015: Fat, fibre and colorectal cancer risk, two-week diet swap between African Americans and people in rural South Africa (Nature Communications)
- Bouvard et al. 2015: IARC evaluation of the carcinogenicity of red and processed meat (Lancet Oncology)
- Spencer et al. 2021: Fibre, probiotics and response to immunotherapy in melanoma, 128 people (Science)
- Wei et al. 2018: Probiotics against diarrhoea during chemotherapy and radiation, Cochrane review
- Bretthauer et al. 2022: NordICC, screening colonoscopy, randomised with 84,585 people (New England Journal of Medicine)
- Astin et al. 2011: Diagnostic value of symptoms for colorectal cancer in primary care, systematic review (British Journal of General Practice)
- Ford et al. 2014: Helicobacter treatment to prevent stomach cancer, meta-analysis of six randomised trials (BMJ)
- Malfertheiner et al. 2022: Maastricht VI consensus on Helicobacter pylori (Gut)
- Routy et al. 2018: Gut microbiota and antibiotics influence the effect of PD-1 immunotherapy (Science)
- Boleij et al. 2011: Streptococcus gallolyticus in the blood and colorectal cancer, meta-analysis (Clinical Infectious Diseases)
- Burn et al. 2020: Aspirin in Lynch syndrome, CAPP2 trial over ten years (The Lancet)
- Davar et al. 2021: Faecal transplant overcomes resistance to immunotherapy in 6 of 15 people with melanoma (Science)
- Díaz-Gay et al. 2025: Mutation patterns in 981 colorectal cancer genomes from 11 countries, colibactin more common in early-onset cancer (Nature)
- Pleguezuelos-Manzano et al. 2020: Typical mutation pattern from colibactin-producing E. coli in colorectal cancer (Nature)
- Bullman et al. 2017: Fusobacterium travels into metastases, antibiotic slows tumours in mice (Science)
- Komiya et al. 2019: The same Fusobacterium strains in colorectal cancer and mouth (Gut)
- Gutmacher et al. 2025: Fusobacterium in saliva does not indicate colorectal cancer, meta-analysis (Scientific Reports)
- Olén et al. 2020: Colorectal cancer in ulcerative colitis, 96,447 patients in Denmark and Sweden (The Lancet)
Your progress
Log in to mark chapters as read, rate them or report them for review. An account is optional and free.
Is something wrong here?
If you think something is wrong, outdated or misleading, report it for review. Every report is read and answered.
Log in to mark chapters as read, rate them or report them for review. An account is optional and free.